V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20203347 | 20167241 | 1.59 | 71.6 | null | 2019-01-02 | 2019-01-09 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100089152 |
| 20203363 | 20167242 | 1.69 | 61.5 | Palliative (P) | 2020-01-27 | 2020-01-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101489653 |
| 20203397 | 20167243 | 1.76 | 66 | Palliative (P) | 2019-12-24 | 2020-01-10 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101742170 |
| 20203399 | 20167244 | 1.7 | 67.2 | null | 2017-11-04 | 2018-04-03 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100099016 |
| 20203419 | 20167245 | 1.79 | 84.7 | Palliative (P) | 2018-06-18 | 2018-06-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100065267 |
| 20203434 | 20167246 | 1.62 | 89.4 | Palliative (P) | 2022-02-09 | 2022-02-23 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101186502 |
| 20203436 | 20167247 | 1.3 | 57.6 | Palliative (P) | 2021-02-16 | 2021-03-22 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101133205 |
| 20203446 | 20167248 | 1.67 | 55.5 | Adjuvant (A) | 2021-06-24 | 2021-07-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101847917 |
| 20203455 | 20167249 | 1.61 | 79.1 | null | 2016-03-28 | 2016-05-15 | Docetaxel | 02 | null | DOCETAXEL | 100655052 |
| 20203462 | 20167250 | 1.88 | 40 | null | 2017-08-10 | 2017-08-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | DOCETAXEL | 100133810 |
| 20203488 | 20167251 | 1.52 | 45.4 | Palliative (P) | 2019-11-14 | 2019-11-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101094784 |
| 20203492 | 20167252 | null | 70 | Adjuvant (A) | 2018-03-15 | 2018-04-05 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100060332 |
| 20203504 | 20167253 | 1.66 | 69.7 | Palliative (P) | 2019-12-04 | 2019-12-04 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101448780 |
| 20203548 | 20167254 | 1.55 | 79 | Palliative (P) | 2018-12-28 | 2019-02-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100961359 |
| 20203562 | 20167255 | null | 55.65 | Palliative (P) | 2018-09-30 | 2018-10-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100710569 |
| 20203586 | 20167256 | 0 | 54.4 | Palliative (P) | 2020-03-14 | 2020-06-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101313322 |
| 20203590 | 20167257 | 1.72 | 70 | Neo-adjuvant (N) | 2016-05-30 | 2016-06-14 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100201819 |
| 20203620 | 20167258 | 1.58 | 55.8 | Adjuvant (A) | 2022-04-23 | 2022-05-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101591673 |
| 20203655 | 20167259 | 1.68 | 78.3 | null | 2017-10-25 | 2017-11-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100910569 |
| 20203665 | 20167260 | 1.75 | 70 | Palliative (P) | 2016-09-16 | 2018-02-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101698536 |
| 20203689 | 20167261 | 1.76 | 77.6 | Adjuvant (A) | 2018-10-15 | 2018-11-16 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100936540 |
| 20203703 | 20167262 | 1.81 | 78 | null | 2021-02-05 | 2021-08-03 | Docetaxel | N | null | DOCETAXEL | 100119109 |
| 20203729 | 20167263 | 1.64 | 53.7 | null | 2017-09-15 | 2018-05-29 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 101031018 |
| 20203732 | 20167264 | 1.59 | 112 | null | 2017-06-18 | 2017-07-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101118909 |
| 20203735 | 20167265 | 1.7 | 71.4 | Adjuvant (A) | 2018-06-20 | 2018-09-02 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101006629 |
| 20203758 | 20167266 | 1.66 | 67.4 | Palliative (P) | 2017-08-17 | 2018-11-07 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100692002 |
| 20203766 | 20167267 | 1.5 | 66 | Palliative (P) | 2017-05-04 | 2017-12-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101230921 |
| 20203782 | 20167268 | 1.74 | 59.85 | Palliative (P) | 2019-04-28 | 2019-05-02 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 101796870 |
| 20203783 | 20167269 | 1.53 | 89 | Adjuvant (A) | 2020-02-05 | 2020-02-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101683338 |
| 20203793 | 20167270 | 1.69 | 85.8 | null | 2020-05-08 | 2020-05-28 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101760475 |
| 20203794 | 20167271 | 1.69 | 72.8 | Neo-adjuvant (N) | 2017-09-09 | 2017-10-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100679328 |
| 20203795 | 20167272 | 1.7 | 56.1 | null | 2018-11-14 | 2018-11-22 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101782326 |
| 20203818 | 20167273 | 1.83 | 58 | Neo-adjuvant (N) | 2019-11-06 | 2019-11-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100334194 |
| 20203831 | 20167274 | 1.65 | 86 | Adjuvant (A) | 2021-08-17 | 2021-08-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100654285 |
| 20203834 | 20167275 | 1.82 | 84.4 | null | 2018-12-31 | 2019-01-14 | Docetaxel | 02 | null | DOCETAXEL | 100542706 |
| 20203859 | 20167276 | 1.47 | 80.3 | Palliative (P) | 2018-10-24 | 2019-02-28 | Cetuximab + FLUOROURACIL + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100134078 |
| 20203871 | 20167277 | 1.59 | 58.2 | Palliative (P) | 2022-01-11 | 2022-01-13 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 101823869 |
| 20203873 | 20167278 | 1.68 | 69.3 | Neo-adjuvant (N) | 2021-10-10 | 2021-10-13 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100164226 |
| 20203884 | 20167279 | 1.74 | 109 | null | 2018-05-01 | 2018-05-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101487049 |
| 20203885 | 20167280 | 1.7 | 80 | Palliative (P) | 2016-07-15 | 2017-11-28 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101211893 |
| 20203888 | 20167281 | 1.74 | 68.9 | Neo-adjuvant (N) | 2017-01-11 | 2017-02-01 | Docetaxel | N | N | DOCETAXEL | 101108119 |
| 20203908 | 20167282 | 1.82 | 104 | Palliative (P) | 2021-06-20 | 2021-07-07 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100030654 |
| 20203936 | 20167283 | 1.7 | 88.45 | Palliative (P) | 2020-12-24 | 2020-12-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101378741 |
| 20203937 | 20167284 | 1.84 | 80 | null | 2020-07-24 | 2020-08-13 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100881217 |
| 20203940 | 20167285 | 1.66 | 79.8 | null | 2019-10-14 | 2019-10-14 | Cetuximab + FOLFIRI cycle1 | 02 | null | CAPECITABINE + GEMCITABINE | 100920196 |
| 20203948 | 20167286 | 1.6 | 64.4 | Palliative (P) | 2021-08-21 | 2021-11-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101632498 |
| 20204000 | 20167287 | 1.69 | 70.6 | Palliative (P) | 2018-10-03 | 2018-10-05 | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101731293 |
| 20204002 | 20167288 | 1.61 | 71 | null | 2015-09-12 | 2016-03-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101176113 |
| 20204021 | 20167289 | 1.85 | 52 | null | 2016-10-01 | 2016-10-09 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101364261 |
| 20204026 | 20167290 | 1.74 | 73.1 | Palliative (P) | 2021-08-01 | 2021-08-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101282031 |